Trials / Completed
CompletedNCT06419660
A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood
The Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of a Single Oral Dose BI 3000202 in Healthy Male Subjects (an Open-label, Randomized, Two-way Cross-over Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect of the proton pump inhibitor esomeprazole on the pharmacokinetics of BI 3000202 in plasma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 300202 | BI 300202 |
| DRUG | esomeprazole | esomeprazole |
Timeline
- Start date
- 2024-05-22
- Primary completion
- 2024-07-08
- Completion
- 2024-07-08
- First posted
- 2024-05-17
- Last updated
- 2025-01-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06419660. Inclusion in this directory is not an endorsement.